4.7 Article

Contribution of Genetically Restricted, Methicillin-Susceptible Strains to the Ongoing Epidemic of Community-Acquired Staphylococcus aureus Infections

期刊

CLINICAL INFECTIOUS DISEASES
卷 49, 期 4, 页码 536-542

出版社

OXFORD UNIV PRESS INC
DOI: 10.1086/600881

关键词

-

资金

  1. National Institutes of Health [K08-DK067894, UL1-RR024992]
  2. Washington University Department of Pediatrics

向作者/读者索取更多资源

Background. Within the current worldwide epidemic of community-acquired Staphylococcus aureus infections, attention has focused on the role of methicillin-resistant strains. We characterize methicillin-susceptible strains that also contribute to this epidemic. Methods. We tracked cultures from abscess specimens submitted to the microbiology laboratory at St. Louis Children's Hospital and examined Panton-Valentine leukocidin (PVL) genes in methicillin-susceptible S. aureus (MSSA) isolates. We further characterized some isolates by multilocus sequence typing, pulsed-field gel electrophoresis, antibiotic susceptibility, accessory gene regulator (agr) allele, and presence of the arcA gene of the arginine catabolic mobile element. Results. From 1999 to 2007, we detected a 250-fold increase in cultures of abscesses yielding methicillin-resistant S. aureus (MRSA) and a 5-fold increase in abscess cultures yielding MSSA. MSSA isolates from abscesses and wounds were more likely to encode PVL than isolates from other sources. In contrast to PVL-negative isolates of MSSA, which were genetically diverse, PVL-positive isolates were predominantly multilocus sequence typing type 8 and agr type 1. More than half of PVL-positive MSSA isolates were resistant to erythromycin and susceptible to clindamycin with the absence of inducible resistance, a pattern uncommon in PVL-negative MSSA but frequent in the USA300 clone of MRSA. In addition, pulsed-field gel electrophoresis of PVL-positive MSSA strains revealed the USA300 pattern. Conclusions. In addition to methicillin-resistant strains, the current epidemic of S. aureus infections includes infections caused by methicillin-susceptible strains that are closely related genetically and share phenotypic characteristics other than susceptibility to methicillin. These findings suggest that factors other than methicillin resistance are driving the epidemic.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Infectious Diseases

Longitudinal, strain-specific Staphylococcus aureus introduction and transmission events in households of children with community-associated meticillin-resistant S aureus skin and soft tissue infection: a prospective cohort study

Ryan L. Mork, Patrick G. Hogan, Carol E. Muenks, Mary G. Boyle, Ryley M. Thompson, Melanie L. Sullivan, John J. Morelli, Jennifer Seigel, Rachel C. Orscheln, Juliane Bubeck Wardenburg, Sarah J. Gehlert, Carey-Ann D. Burnham, Andrey Rzhetsky, Stephanie A. Fritz

LANCET INFECTIOUS DISEASES (2020)

Review Pediatrics

Sex effects in pyelonephritis

Clayton D. Albracht, Teri N. Hreha, David A. Hunstad

Summary: Urinary tract infections (UTIs) are not only a disease that affects women, but also certain male populations such as infants and elderly men. High-grade vesicoureteral reflux is a primary risk factor for upper-tract UTI in children. Recent studies indicate that there are sex and hormone-specific effects on UTI pathogenesis and immune responses.

PEDIATRIC NEPHROLOGY (2021)

Article Oncology

Incidence and treatment of hemophagocytic lymphohistiocytosis in hospitalized children with Ehrlichia infection

Stephanie S. Cabler, Patrick G. Hogan, Stephanie A. Fritz, Jeffrey J. Bednarski, David A. Hunstad

PEDIATRIC BLOOD & CANCER (2020)

Editorial Material Pediatrics

Practical School Algorithms for Symptomatic or SARS-CoV-2-Exposed Students Are Essential for Returning Children to In-Person Learning

Rachel C. Orscheln, Jason G. Newland, David A. Rosen

JOURNAL OF PEDIATRICS (2021)

Article Public, Environmental & Occupational Health

Pilot Investigation of SARS-CoV-2 Secondary Transmission in Kindergarten Through Grade 12 Schools Implementing Mitigation Strategies - St. Louis County and City of Springfield, Missouri, December 2020

Patrick Dawson, Mary Claire Worrell, Sara Malone, Sarah C. Tinker, Stephanie Fritz, Brett Maricque, Sadaf Junaidi, Gemille Purnell, Albert M. Lai, Julie A. Neidich, Justin S. Lee, Rachel C. Orscheln, Rachel Charney, Terri Rebmann, Jon Mooney, Nancy Yoon, Machelle Petit, Spring Schmidt, Jean Grabeel, Lee Ann Neill, Lisa C. Barrios, Snigdha Vallabhaneni, Randall W. Williams, Clay Goddard, Jason G. Newland, John C. Neatherlin, Johanna S. Salzer

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2021)

Letter Immunology

X-linked Chronic Granulomatous Disease Presenting with Mediastinal Lipoblastoma and Adjacent Pneumonia

Tarin M. Bigley, Zhimin Song, Rachel C. Orscheln, David B. Wilson, Baddr A. Shakhsheer, Mai He, Stuart C. Sweet, Mary C. Dinauer, Maleewan Kitcharoensakkul

JOURNAL OF CLINICAL IMMUNOLOGY (2021)

Review Immunology

Immune defenses in the urinary tract

Hunter W. Kuhn, Teri N. Hreha, David A. Hunstad

Summary: Recent advances in preclinical modeling of urinary tract infections have provided new insights into the host response and tissue damage. The roles of neutrophils, macrophages, antimicrobial peptides, and renal epithelial cells in controlling uropathogens and tissue injury have been explored. Epigenetic modifications during bacterial cystitis have also been linked to bladder remodeling and increased susceptibility to recurrent UTI. This research could inform the development of preventive and therapeutic approaches for UTI.

TRENDS IN IMMUNOLOGY (2023)

Article Infectious Diseases

Return to School and COVID-19 Vaccination for Pediatric Solid Organ Transplant Recipients in the United States: Expert Opinion for 2021-2022

Kevin J. Downes, Victoria A. Statler, Rachel C. Orscheln, Melissa K. Cousino, Michael Green, Marian G. Michaels, William J. Muller, Tanvi S. Sharma, Lara A. Danziger-Isakov, Monica Ardura

Summary: The COVID-19 pandemic poses challenges for pediatric solid organ transplant recipients and their families, particularly regarding school re-entry and COVID-19 vaccines. A team of specialists in various fields assembled to address these concerns and provide expert statements specific to pediatric SOT recipients attending school in the United States in 2021.

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2022)

Article Immunology

Sex Differences in Population Dynamics during Formation of Kidney Bacterial Communities by Uropathogenic Escherichia coli

Lisa K. McLellan, Allyssa L. Daugherty, David A. Hunstad

Summary: Uropathogenic Escherichia coli (UPEC) encounters a bottleneck in the female bladder during cystitis, but males show a less restrictive bottleneck during successful renal infection. The study also found that kidney bacterial communities (KBCs) are clonal in origin despite the influx of infected bladder urine into the renal pelvis.

INFECTION AND IMMUNITY (2021)

Article Infectious Diseases

Initial Guidance on Use of Monoclonal Antibody Therapy for Treatment of Coronavirus Disease 2019 in Children and Adolescents

Joshua Wolf, Mark J. Abzug, Rachel L. Wattier, Paul K. Sue, Surabhi B. Vora, Philip Zachariah, Daniel E. Dulek, Alpana Waghmare, Rosemary Olivero, Kevin J. Downes, Scott H. James, Swetha G. Pinninti, April Yarbrough, Margaret L. Aldrich, Christine E. MacBrayne, Vijaya L. Soma, Steven P. Grapentine, Carlos R. Oliveira, Molly Hayes, David W. Kimberlin, Sarah B. Jones, Laura L. Bio, Theodore H. Morton, Jane S. Hankins, Gabriela M. Maron, Kathryn Timberlake, Jennifer L. Young, Rachel C. Orscheln, Hayden T. Schwenk, David L. Goldman, Helen E. Groves, W. Charles Huskins, Nipunie S. Rajapakse, Gabriella S. Lamb, Alison C. Tribble, Elizabeth C. Lloyd, Adam L. Hersh, Emily A. Thorell, Adam J. Ratner, Kathleen Chiotos, Mari M. Nakamura

Summary: This study suggests that there is currently no evidence supporting the use of monoclonal antibody therapy for treating COVID-19 in children or adolescents, despite the typically mild course of the disease in this population. Limited evidence of modest benefit in adults is available, but there is a risk of potential harm associated with infusion reactions or anaphylaxis.

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2021)

Article Infectious Diseases

Skin and Soft Tissue Infection Treatment and Prevention Practices by Pediatric Infectious Diseases Providers

Katelyn L. Parrish, Noble K. Salwan, Ryley M. Thompson, Patrick G. Hogan, Rachel C. Orscheln, Jason G. Newland, Stephanie A. Fritz

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2020)

Article Infectious Diseases

Return to School for Pediatric Solid Organ Transplant Recipients in the United States During the Coronavirus Disease 2019 Pandemic: Expert Opinion on Key Considerations and Best Practices

Kevin J. Downes, Lara A. Danziger-Isakov, Melissa K. Cousino, Michael Green, Marian G. Michaels, William J. Muller, Rachel C. Orscheln, Tanvi S. Sharma, Victoria A. Statler, Rachel L. Wattier, Monica Ardura

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2020)

Article Infectious Diseases

Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2

Kathleen Chiotos, Molly Hayes, David W. Kimberlin, Sarah B. Jones, Scott H. James, Swetha G. Pinninti, April Yarbrough, Mark J. Abzug, Christine E. MacBrayne, Vijaya L. Soma, Daniel E. Dulek, Surabhi B. Vora, Alpana Waghmare, Joshua Wolf, Rosemary Olivero, Steven Grapentine, Rachel L. Wattier, Laura Bio, Shane J. Cross, Nicholas O. Dillman, Kevin J. Downes, Kathryn Timberlake, Jennifer Young, Rachel C. Orscheln, Pranita D. Tamma, Hayden T. Schwenk, Philip Zachariah, Margaret Aldrich, David L. Goldman, Helen E. Groves, Gabriella S. Lamb, Alison C. Tribble, Adam L. Hersh, Emily A. Thorell, Mark R. Denison, Adam J. Ratner, Jason G. Newland, Mari M. Nakamura

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2020)

Article Physiology

TGFβ1 orchestrates renal fibrosis following Escherichia coli pyelonephritis

Teri N. Hreha, Christina A. Collins, Allyssa L. Daugherty, Joy Twentyman, Nitin Paluri, David A. Hunstad

PHYSIOLOGICAL REPORTS (2020)

Review Infectious Diseases

Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2

Kathleen Chiotos, Molly Hayes, David W. Kimberlin, Sarah B. Jones, Scott H. James, Swetha G. Pinninti, April Yarbrough, Mark J. Abzug, Christine E. MacBrayne, Vijaya L. Soma, Daniel E. Dulek, Surabhi B. Vora, Alpana Waghmare, Joshua Wolf, Rosemary Olivero, Steven Grapentine, Rachel L. Wattier, Laura Bio, Shane J. Cross, Nicholas O. Dillman, Kevin J. Downes, Carlos R. Oliveira, Kathryn Timberlake, Jennifer Young, Rachel C. Orscheln, Pranita D. Tamma, Hayden T. Schwenk, Philip Zachariah, Margaret L. Aldrich, David L. Goldman, Helen E. Groves, Nipunie S. Rajapakse, Gabriella S. Lamb, Alison C. Tribble, Adam L. Hersh, Emily A. Thorell, Mark R. Denison, Adam J. Ratner, Jason G. Newland, Mari M. Nakamura

Summary: Although COVID-19 is usually mild in children, some may develop severe or critical illness. Supportive care is typically enough for most cases, but for severe cases, remdesivir is suggested, with a duration of 5 days. It is not recommended to use hydroxychloroquine or other protease inhibitors for COVID-19 in children.

JOURNAL OF THE PEDIATRIC INFECTIOUS DISEASES SOCIETY (2021)

暂无数据